Annual EBIT
-$40.02 M
-$32.43 M-427.23%
December 1, 2023
Summary
- As of February 7, 2025, CATX annual earnings before interest & taxes is -$40.02 million, with the most recent change of -$32.43 million (-427.23%) on December 1, 2023.
- During the last 3 years, CATX annual EBIT has fallen by -$36.59 million (-1064.45%).
- CATX annual EBIT is now -114.59% below its all-time high of $274.37 million, reached on June 1, 2005.
Performance
CATX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$15.05 M
-$3.86 M-34.51%
September 1, 2024
Summary
- As of February 7, 2025, CATX quarterly earnings before interest & taxes is -$15.05 million, with the most recent change of -$3.86 million (-34.51%) on September 1, 2024.
- Over the past year, CATX quarterly EBIT has dropped by -$5.50 million (-57.49%).
- CATX quarterly EBIT is now -5017766.67% below its all-time high of $300.00, reached on September 1, 2002.
Performance
CATX Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$49.66 M
-$5.50 M-12.44%
September 1, 2024
Summary
- As of February 7, 2025, CATX TTM earnings before interest & taxes is -$49.66 million, with the most recent change of -$5.50 million (-12.44%) on September 1, 2024.
- Over the past year, CATX TTM EBIT has dropped by -$21.25 million (-74.82%).
- CATX TTM EBIT is now -1839048.15% below its all-time high of -$2700.00, reached on December 1, 1998.
Performance
CATX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
CATX EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -427.2% | -57.5% | -74.8% |
| 3 y3 years | -1064.5% | -60.4% | -216.3% |
| 5 y5 years | -658.3% | -60.4% | -216.3% |
CATX EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -1064.5% | at low | -994.0% | at low | -761.2% | at low |
| 5 y | 5-year | -1064.5% | at low | -2646.9% | at low | -1397.0% | at low |
| alltime | all time | -114.6% | at low | <-9999.0% | at low | <-9999.0% | at low |
Perspective Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$15.05 M(+34.5%) | -$49.66 M(+12.4%) |
| Jun 2024 | - | -$11.19 M(-5.1%) | -$44.16 M(+4.1%) |
| Mar 2024 | - | -$11.80 M(+1.5%) | -$42.43 M(+6.0%) |
| Dec 2023 | -$40.02 M(+427.2%) | -$11.62 M(+21.5%) | -$40.02 M(+40.9%) |
| Sep 2023 | - | -$9.56 M(+1.0%) | -$28.41 M(+23.2%) |
| Jun 2023 | - | -$9.46 M(+0.8%) | -$23.05 M(+46.8%) |
| Mar 2023 | - | -$9.39 M(+123.1%) | -$15.70 M(+68.4%) |
| Dec 2022 | -$7.59 M(+2.7%) | - | - |
| Sep 2022 | - | -$4.21 M(+99.8%) | -$9.32 M(+26.2%) |
| Jun 2022 | - | -$2.11 M(+53.1%) | -$7.39 M(+15.9%) |
| Jun 2022 | -$7.39 M(+115.0%) | - | - |
| Mar 2022 | - | -$1.38 M(-15.8%) | -$6.38 M(+10.6%) |
| Dec 2021 | - | -$1.64 M(-28.1%) | -$5.77 M(+15.4%) |
| Sep 2021 | - | -$2.27 M(+108.1%) | -$5.00 M(+45.4%) |
| Jun 2021 | -$3.44 M(-1.1%) | - | - |
| Jun 2021 | - | -$1.09 M(+43.1%) | -$3.44 M(-2.7%) |
| Mar 2021 | - | -$764.00 K(-11.8%) | -$3.53 M(+6.5%) |
| Dec 2020 | - | -$866.00 K(+21.3%) | -$3.32 M(-1.1%) |
| Sep 2020 | - | -$714.00 K(-39.9%) | -$3.35 M(-3.5%) |
| Jun 2020 | -$3.48 M(-34.1%) | -$1.19 M(+117.0%) | -$3.48 M(+1.3%) |
| Mar 2020 | - | -$548.00 K(-39.3%) | -$3.43 M(-15.2%) |
| Dec 2019 | - | -$903.00 K(+8.0%) | -$4.05 M(-11.9%) |
| Sep 2019 | - | -$836.00 K(-26.9%) | -$4.60 M(-12.9%) |
| Jun 2019 | -$5.28 M(-21.6%) | -$1.14 M(-1.7%) | -$5.28 M(-18.8%) |
| Mar 2019 | - | -$1.16 M(-19.8%) | -$6.50 M(-2.6%) |
| Dec 2018 | - | -$1.45 M(-4.3%) | -$6.68 M(-0.2%) |
| Sep 2018 | - | -$1.52 M(-35.9%) | -$6.70 M(-0.5%) |
| Jun 2018 | -$6.73 M(+6.7%) | -$2.37 M(+77.0%) | -$6.73 M(+8.1%) |
| Mar 2018 | - | -$1.34 M(-8.8%) | -$6.22 M(-0.8%) |
| Dec 2017 | - | -$1.47 M(-5.4%) | -$6.28 M(-0.2%) |
| Sep 2017 | - | -$1.55 M(-16.8%) | -$6.29 M(-0.4%) |
| Jun 2017 | -$6.31 M(+33.9%) | -$1.87 M(+34.3%) | -$6.31 M(+18.5%) |
| Mar 2017 | - | -$1.39 M(-6.1%) | -$5.33 M(+1.2%) |
| Dec 2016 | - | -$1.48 M(-6.1%) | -$5.26 M(+1.3%) |
| Sep 2016 | - | -$1.57 M(+78.6%) | -$5.19 M(+10.3%) |
| Jun 2016 | -$4.71 M(+28.0%) | -$882.00 K(-33.5%) | -$4.71 M(-3.2%) |
| Mar 2016 | - | -$1.33 M(-5.9%) | -$4.86 M(+8.3%) |
| Dec 2015 | - | -$1.41 M(+29.2%) | -$4.49 M(+12.6%) |
| Sep 2015 | - | -$1.09 M(+5.3%) | -$3.99 M(+8.4%) |
| Jun 2015 | -$3.68 M(-38.3%) | -$1.04 M(+8.7%) | -$3.68 M(-14.8%) |
| Mar 2015 | - | -$953.50 K(+5.1%) | -$4.32 M(-20.7%) |
| Dec 2014 | - | -$907.00 K(+15.9%) | -$5.45 M(-0.4%) |
| Sep 2014 | - | -$782.40 K(-53.4%) | -$5.47 M(-8.2%) |
| Jun 2014 | -$5.96 M(+54.5%) | -$1.68 M(-19.5%) | -$5.96 M(+13.0%) |
| Mar 2014 | - | -$2.08 M(+124.8%) | -$5.27 M(+35.0%) |
| Dec 2013 | - | -$926.90 K(-27.0%) | -$3.91 M(-5.5%) |
| Sep 2013 | - | -$1.27 M(+27.8%) | -$4.13 M(+7.2%) |
| Jun 2013 | -$3.86 M(+12.5%) | -$993.60 K(+39.0%) | -$3.86 M(-3.9%) |
| Mar 2013 | - | -$715.00 K(-38.1%) | -$4.01 M(+4.3%) |
| Dec 2012 | - | -$1.15 M(+16.2%) | -$3.85 M(+15.9%) |
| Sep 2012 | - | -$993.70 K(-13.6%) | -$3.32 M(-3.2%) |
| Jun 2012 | -$3.43 M(+15.7%) | -$1.15 M(+109.2%) | -$3.43 M(+12.6%) |
| Mar 2012 | - | -$549.60 K(-12.2%) | -$3.04 M(-4.5%) |
| Dec 2011 | - | -$625.80 K(-43.2%) | -$3.19 M(-0.3%) |
| Sep 2011 | - | -$1.10 M(+43.8%) | -$3.20 M(+7.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2011 | -$2.96 M(-25.9%) | -$766.40 K(+10.5%) | -$2.96 M(-9.2%) |
| Mar 2011 | - | -$693.40 K(+9.3%) | -$3.26 M(-10.8%) |
| Dec 2010 | - | -$634.60 K(-26.9%) | -$3.66 M(-7.8%) |
| Sep 2010 | - | -$868.50 K(-18.6%) | -$3.97 M(-0.7%) |
| Jun 2010 | -$4.00 M(-38.2%) | -$1.07 M(-2.2%) | -$4.00 M(-4.3%) |
| Mar 2010 | - | -$1.09 M(+15.4%) | -$4.18 M(-8.6%) |
| Dec 2009 | - | -$944.90 K(+5.6%) | -$4.57 M(-19.9%) |
| Sep 2009 | - | -$895.20 K(-28.2%) | -$5.71 M(-11.8%) |
| Jun 2009 | -$6.47 M(-26.5%) | -$1.25 M(-15.9%) | -$6.47 M(-2.3%) |
| Mar 2009 | - | -$1.48 M(-28.8%) | -$6.63 M(-8.4%) |
| Dec 2008 | - | -$2.08 M(+25.6%) | -$7.24 M(-10.6%) |
| Sep 2008 | - | -$1.66 M(+18.3%) | -$8.09 M(-8.1%) |
| Jun 2008 | -$8.80 M(-9.2%) | -$1.40 M(-33.0%) | -$8.80 M(-14.1%) |
| Mar 2008 | - | -$2.09 M(-28.9%) | -$10.25 M(+0.5%) |
| Dec 2007 | - | -$2.94 M(+24.2%) | -$10.19 M(+11.4%) |
| Sep 2007 | - | -$2.37 M(-16.9%) | -$9.15 M(-5.6%) |
| Jun 2007 | -$9.70 M(+34.8%) | -$2.85 M(+39.9%) | -$9.70 M(+5.1%) |
| Mar 2007 | - | -$2.04 M(+7.1%) | -$9.23 M(+6.6%) |
| Dec 2006 | - | -$1.90 M(-34.8%) | -$8.66 M(+4.3%) |
| Sep 2006 | - | -$2.91 M(+22.5%) | -$8.30 M(+15.3%) |
| Jun 2006 | -$7.20 M(-102.6%) | -$2.38 M(+62.6%) | -$7.20 M(+49.4%) |
| Mar 2006 | - | -$1.46 M(-5.2%) | -$4.82 M(+31.8%) |
| Dec 2005 | - | -$1.54 M(-14.8%) | -$3.66 M(+72.7%) |
| Sep 2005 | - | -$1.81 M(+499.7%) | -$2.12 M(+567.1%) |
| Jun 2005 | $274.37 M(<-9900.0%) | - | - |
| Mar 2005 | - | -$302.00 K(+8288.9%) | -$317.30 K(+1777.5%) |
| Dec 2004 | - | -$3600.00(-14.3%) | -$16.90 K(-29.9%) |
| Sep 2004 | -$9100.00(-52.1%) | -$4200.00(-44.0%) | -$24.10 K(-10.4%) |
| Jun 2004 | - | -$7500.00(+368.8%) | -$26.90 K(+26.9%) |
| Mar 2004 | - | -$1600.00(-85.2%) | -$21.20 K(-4.9%) |
| Dec 2003 | - | -$10.80 K(+54.3%) | -$22.30 K(+16.8%) |
| Sep 2003 | -$19.00 K(+150.0%) | -$7000.00(+288.9%) | -$19.10 K(+61.9%) |
| Jun 2003 | - | -$1800.00(-33.3%) | -$11.80 K(+2.6%) |
| Mar 2003 | - | -$2700.00(-64.5%) | -$11.50 K(-16.1%) |
| Dec 2002 | - | -$7600.00(-2633.3%) | -$13.70 K(+80.3%) |
| Sep 2002 | -$7600.00(-51.3%) | $300.00(-120.0%) | -$7600.00(-20.8%) |
| Jun 2002 | - | -$1500.00(-69.4%) | -$9600.00(-49.5%) |
| Mar 2002 | - | -$4900.00(+226.7%) | -$19.00 K(+25.8%) |
| Dec 2001 | - | -$1500.00(-11.8%) | -$15.10 K(-3.8%) |
| Sep 2001 | -$15.60 K(+10.6%) | -$1700.00(-84.4%) | -$15.70 K(-44.1%) |
| Jun 2001 | - | -$10.90 K(+990.0%) | -$28.10 K(+63.4%) |
| Mar 2001 | - | -$1000.00(-52.4%) | -$17.20 K(+6.2%) |
| Dec 2000 | - | -$2100.00(-85.1%) | -$16.20 K(+14.9%) |
| Sep 2000 | -$14.10 K(-9.0%) | -$14.10 K(<-9900.0%) | -$14.10 K(+11.9%) |
| Jun 2000 | - | $0.00(0.0%) | -$12.60 K(-5.3%) |
| Mar 2000 | - | $0.00(0.0%) | -$13.30 K(-3.6%) |
| Dec 1999 | - | $0.00(-100.0%) | -$13.80 K(-16.4%) |
| Sep 1999 | -$15.50 K(-93.0%) | -$12.60 K(+1700.0%) | -$16.50 K(+323.1%) |
| Jun 1999 | - | -$700.00(+40.0%) | -$3900.00(+21.9%) |
| Mar 1999 | - | -$500.00(-81.5%) | -$3200.00(+18.5%) |
| Dec 1998 | - | -$2700.00 | -$2700.00 |
| Sep 1998 | -$222.80 K(-25.7%) | - | - |
| Sep 1997 | -$299.80 K(-85.8%) | - | - |
| Sep 1996 | -$2.11 M(+154.8%) | - | - |
| Sep 1995 | -$827.90 K(-29.1%) | - | - |
| Sep 1994 | -$1.17 M | - | - |
FAQ
- What is Perspective Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Perspective Therapeutics?
- What is Perspective Therapeutics annual EBIT year-on-year change?
- What is Perspective Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Perspective Therapeutics?
- What is Perspective Therapeutics quarterly EBIT year-on-year change?
- What is Perspective Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Perspective Therapeutics?
- What is Perspective Therapeutics TTM EBIT year-on-year change?
What is Perspective Therapeutics annual earnings before interest & taxes?
The current annual EBIT of CATX is -$40.02 M
What is the all time high annual EBIT for Perspective Therapeutics?
Perspective Therapeutics all-time high annual earnings before interest & taxes is $274.37 M
What is Perspective Therapeutics annual EBIT year-on-year change?
Over the past year, CATX annual earnings before interest & taxes has changed by -$32.43 M (-427.23%)
What is Perspective Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of CATX is -$15.05 M
What is the all time high quarterly EBIT for Perspective Therapeutics?
Perspective Therapeutics all-time high quarterly earnings before interest & taxes is $300.00
What is Perspective Therapeutics quarterly EBIT year-on-year change?
Over the past year, CATX quarterly earnings before interest & taxes has changed by -$5.50 M (-57.49%)
What is Perspective Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of CATX is -$49.66 M
What is the all time high TTM EBIT for Perspective Therapeutics?
Perspective Therapeutics all-time high TTM earnings before interest & taxes is -$2700.00
What is Perspective Therapeutics TTM EBIT year-on-year change?
Over the past year, CATX TTM earnings before interest & taxes has changed by -$21.25 M (-74.82%)